Oppenheimer analyst Ken Wong lowered the firm’s price target on Bill (BILL) to $90 from $110 and keeps an Outperform rating on the shares. The ...

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

Oppenheimer analysts reiterated their Outperform rating and $115.00 price target for EnerSys (NYSE:ENS) stock. EnerSys shares experienced a modest increase on Thursday following the company's ...

Albemarle (NYSE:ALB – Get Free Report) was downgraded by research analysts at Evercore ISI from an “outperform” rating to an ...

Patient Capital Management stated the following regarding Coinbase Global, Inc. (NASDAQ:COIN) in its Q4 2024 investor letter: ...

After the music industry gave out its prestigious Grammys Sunday, the film community is gearing up for its ceremony to take ...

Over the years, we’ve heard hundreds of time about how we have enough nuclear weapons to destroy the world. But is that ...

Today, Benzinga's options scanner spotted 11 options trades for American Superconductor. This is not a typical pattern. The sentiment among these major traders is split, with 90% bullish and 9% ...

AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

Hulu has renewed the hit series Tell Me Lies for a third season, sharing on social media: “couldn’t keep you waiting any ...

As the Trump administration continues changing federal research and funding guidelines, the ‘Prince’ spoke to professors and ...